With the determination of the crystal structure of CSAD [33] and the in-depth study of its function and related mechanism, more regulatory factors will be discovered to regulate CSAD in the future, which might also provide more possibilities for the treatment of NAFLD. The gene discussed is CSAD; the disease is metabolic dysfunction-associated steatotic liver disease.